ALXN
Alyeska Investment Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-400,000
| Closed | -$73.5M | – | 886 |
|
|
2021
Q2 | $73.5M | Buy |
400,000
+125,000
| +45% | +$23M | 0.85% | 15 |
|
|
2021
Q1 | $42.1M | Buy |
275,000
+175,694
| +177% | +$26.9M | 0.54% | 41 |
|
|
2020
Q4 | $15.5M | Buy |
+99,306
| New | +$15.5M | 0.22% | 139 |
|
|
2019
Q2 | – | Sell |
-202,671
| Closed | -$27.4M | – | 516 |
|
|
2019
Q1 | $27.4M | Buy |
+202,671
| New | +$27.4M | 0.36% | 87 |
|
|
2017
Q2 | – | Sell |
-11,924
| Closed | -$1.45M | – | 557 |
|
|
2017
Q1 | $1.45M | Sell |
11,924
-775,569
| -98% | -$94.1M | 0.01% | 402 |
|
|
2016
Q4 | $96.4M | Buy |
787,493
+325,965
| +71% | +$39.9M | 0.8% | 17 |
|
|
2016
Q3 | $56.6M | Sell |
461,528
-564,242
| -55% | -$69.1M | 0.52% | 51 |
|
|
2016
Q2 | $120M | Buy |
1,025,770
+725,723
| +242% | +$84.7M | 1.13% | 5 |
|
|
2016
Q1 | $41.8M | Sell |
300,047
-115,990
| -28% | -$16.1M | 0.38% | 89 |
|
|
2015
Q4 | $79.4M | Sell |
416,037
-23,902
| -5% | -$4.56M | 0.84% | 23 |
|
|
2015
Q3 | $68.8M | Buy |
439,939
+126,453
| +40% | +$19.8M | 0.81% | 27 |
|
|
2015
Q2 | $56.7M | Buy |
313,486
+127,992
| +69% | +$23.1M | 0.64% | 25 |
|
|
2015
Q1 | $32.1M | Buy |
185,494
+32,188
| +21% | +$5.58M | 0.45% | 70 |
|
|
2014
Q4 | $28.4M | Buy |
153,306
+30,929
| +25% | +$5.72M | 0.48% | 62 |
|
|
2014
Q3 | $20.3M | Sell |
122,377
-58,155
| -32% | -$9.64M | 0.42% | 75 |
|
|
2014
Q2 | $28.2M | Buy |
180,532
+83,909
| +87% | +$13.1M | 0.63% | 28 |
|
|
2014
Q1 | $14.7M | Buy |
96,623
+11,623
| +14% | +$1.77M | 0.4% | 71 |
|
|
2013
Q4 | $11.3M | Buy |
+85,000
| New | +$11.3M | 0.45% | 66 |
|